Clinical trial
Phase I Drug Trial for S/E of Marimastat in Disabling Malformations When no…
NCT00261391 · Boston Children's Hospital, Other · Completed
Key facts
| NCT number | NCT00261391 |
|---|---|
| Title | Phase I Drug Trial for S/E of Marimastat in Disabling Malformations When no Other Options. |
| Official title | Phase I Dose Escalation Study to Evaluate the Safety and Preliminary Efficacy of Marimastat in Patients With Disabling Malformations and No Other Treatment Options |
| Lead sponsor | Boston Children's Hospital, Other |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Vascular Anomalies |
| Intervention type | Drug |
| Interventions | Marimastat |
| Enrollment | 9 |
| Start date | Oct 1, 2000 |
| Completion | Oct 1, 2007 |
| First posted | Dec 5, 2005 |
| Last update posted | Jan 9, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: